...
首页> 外文期刊>International journal of STD & AIDS >Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis
【24h】

Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis

机译:失去了拯救新生生命的机会:奈瑟氏菌淋病和衣原体粉碎片的变量国家产前筛查政策

获取原文
获取原文并翻译 | 示例

摘要

Unfavorable pregnancy outcomes caused by Chlamydia trachomatis or Neisseria gonorrhoeae infection are well known. The first step in addressing antenatal C. trachomatis and N. gonorrhoeae infection is a national policy to screen all pregnant women for C. trachomatis and N. gonorrhoeae, regardless of symptoms. The aim of this study was to inform policy makers on the presence of antenatal screening recommendations for C. trachomatis and N. gonorrhoeae infection. We conducted a three-part study from June 2015 to February 2016. We analyzed English and French language information online on Ministry of Health websites regarding C. trachomatis and N. gonorrhoeae antenatal screening. We referenced both primary official country and regional policy documents. We contacted the Ministry of Health directly if the information on the national antenatal screening was outdated or unavailable. In parallel, we sent a survey to the regional representative from the World Health Organization to help collect country-level data. Fourteen countries have current policies for antenatal screening of C. trachomatis and/or N. gonorrhoeae infection: Australia, the Bahamas, Bulgaria, Canada, Estonia, Japan, Germany, Latvia, New Zealand, Democratic People's Republic of Korea, Romania, Sweden, the United Kingdom, and the United States. Australia, New Zealand, and Latvia and the United States restricted antenatal screening to women 25 years old and those of higher risk. Several countries responded that they had policies to treat pregnant women with symptoms. This is the currently recommended WHO guideline but is not the same as universal screening. North Korea had policies in place which were not implemented due to lack of personnel and/or supplies. National level policies to support routine screening for C. trachomatis and N. gonorrhoeae infection to prevent adverse pregnancy and newborn outcomes are uncommon.
机译:由衣原体衣原体或奈瑟氏淋病淋病感染引起的不利妊娠结果是众所周知的。寻址产前癌的第一步C. thachomatis和N.淋病感染是一种国家政策,用于筛选所有孕妇C. Thachomatis和N.Gonorrhoeae,无论症状如何。本研究的目的是为政策制定者提供对C. Thachomatis和N.淋病感染的产前筛查建议。我们从2015年6月到2016年2月进行了三部分研究。我们在网上在线分析了关于C. Thachomatis和N.淋病术后产前筛查的卫生网站的英语和法语信息。我们引用了主要官方国家和区域政策文件。如果国家产前筛查的信息过时或无法使用,我们直接联系了卫生部。并行,我们向世界卫生组织的区域代表发出了一项调查,以帮助收集国家级数据。十四个国家对C. Tachomatis和/或N.淋病感染的天然产物筛查政策:澳大利亚,巴哈马,保加利亚,加拿大,爱沙尼亚,日本,德国,拉脱维亚,新西兰,民主人民共和国大韩民国,罗马尼亚,瑞典,英国和美国。澳大利亚,新西兰和拉脱维亚和美国限制了25岁及更高风险的女性的产前筛查。有几个国家的回应说,他们有政治治疗患有症状的孕妇。这是目前推荐的谁指导,但与通用筛选不同。朝鲜有政策,由于缺乏人员和/或供应而没有实施。国家一级政策支持C. Thachomatis和N.淋病感染的常规筛查,以防止不良妊娠和新生儿结果罕见。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号